Graded Effects of Proteinuria on HDL Structure in Nephrotic Rats
- 1 May 2005
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 16 (5) , 1309-1319
- https://doi.org/10.1681/asn.2004080644
Abstract
Nephrotic syndrome is characterized by increased triglycerides resulting from decreased clearance of VLDL and chylomicrons. These triglyceride-rich lipoproteins are structurally altered by interaction with HDL derived from animals with proteinuria and not as a consequence of hypoalbuminemia. HDL isolated from rats with massive proteinuria is depleted in apolipoprotein E (apoE). It is unknown at what threshold of urinary albumin loss HDL structure is altered, and it is unknown what effects proteinuria has on apolipoproteins other than apoE. Two models of albuminuria were used in Sprague-Dawley rats: Adriamycin and passive Heymann nephritis (HN). The adriamycin group was divided into minimal albumin excretion (MAE) and intermediate albumin excretion (MAE, 1 to 40; intermediate albumin excretion, 60 to 210 mg/d per 100 g body wt). Urinary albumin excretion exceeded 300 mg/d per 100 g body wt in the HN rats. HDL apolipoprotein composition was analyzed with SDS-PAGE densitometry and liquid chromatography–time of flight mass spectrometer mass spectrometry. HDL apoA-IV content relative to apoA-I was reduced at all levels of albuminuria (P < 0.0001). ApoE was not reduced in MAE but was significantly reduced in IAE (72%; P < 0.001). By contrast, apoA-II and apoC-III were each significantly increased with increasing UAE. ApoA-IV and apoE were decreased to approximately 10% of control in HDL isolated from rats with HN, whereas apoA-II, apoC-II, and apoC-III were each significantly increased relative to apoA-I. HDL is structurally altered by levels of albuminuria that are insufficient to change serum albumin levels and is progressively altered as albuminuria increases.Keywords
This publication has 59 references indexed in Scilit:
- Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDLKidney International, 2004
- Are triglyceride-rich lipoproteins associated with aortic valve sclerosis? A preliminary reportAtherosclerosis, 2003
- Microalbuminuria and Pulse Pressure in Hypertensive and Atherosclerotic MenHypertension, 2000
- Apolipoprotein C-III, Hypertriglyceridemia and Triglyceride-Rich Lipoproteins in UremiaMineral and Electrolyte Metabolism, 1999
- Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesisKidney International, 1998
- Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and EArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Regulation of apolipoprotein gene expression and plasma high-density lipoprotein composition in experimental nephrosisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Serum and urinary high density lipoproteins in glomerular disease with proteinuriaKidney International, 1986
- Catabolism of the apolipoproteins of HDL in control and nephrotic ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoproteinBiochemical and Biophysical Research Communications, 1972